Condition: Endometrial Cancer · Sponsor: WellSpan Health
This study aims to answer whether use of a Vcare® intrauterine manipulator leads to an increased incidence of positive peritoneal cytology in patients undergoing surgical management of early stage (FIGO stage I/II) endometrial cancer.
This description comes directly from the study's public registry record.
Graham Brown, DO · 717-851-6120 · gbrown5@wellspan.org
Eav Lim, DO · 717-851-6120 · elim@wellspan.org
Always discuss trial participation with your own doctor first.
| Wellspan Health | York, Pennsylvania, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04570553